Honokiol-mesoporous Silica Nanoparticles Inhibit Vascular Restenosis via the Suppression of TGF-β Signaling Pathway
Xiao Wei,1,* Zhiwei Fang,2,* Jing Sheng,1 Yu Wang,3 Ping Lu1 1Department of Geriatrics, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, People’s Republic of China; 2Engineering Research Center of Cell & Therapeutic Anti...
Guardado en:
Autores principales: | Wei X, Fang Z, Sheng J, Wang Y, Lu P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e25094edd844b2d975a2e736f4804f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Silica nanoparticles induce liver fibrosis via TGF-β1/Smad3 pathway in ICR mice
por: Yu Y, et al.
Publicado: (2017) -
Repeated intravenous administration of silica nanoparticles induces pulmonary inflammation and collagen accumulation via JAK2/STAT3 and TGF-β/Smad3 pathways in vivo
por: Yu Y, et al.
Publicado: (2019) -
TGF-β Signaling and Resistance to Cancer Therapy
por: Maoduo Zhang, et al.
Publicado: (2021) -
Short-Term Oral Administration of Mesoporous Silica Nanoparticles Potentially Induced Colon Inflammation in Rats Through Alteration of Gut Microbiota
por: Yu Y, et al.
Publicado: (2021) -
Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
por: Wu W, et al.
Publicado: (2018)